TY - JOUR
T1 - Growth patterns of uninfected children born to women living with perinatally versus nonperinatally acquired HIV
AU - the Pediatric HIV/AIDS Cohort Study (PHACS)
AU - Yu, Wendy
AU - Jacobson, Denise L.
AU - Williams, Paige L.
AU - Patel, Kunjal
AU - Geffner, Mitchell E.
AU - van Dyke, Russell B.
AU - Kacanek, Deborah
AU - DiMeglio, Linda A.
AU - Jao, Jennifer
AU - Chadwick, Ellen
AU - Sanders, Margaret Ann
AU - Malee, Kathleen
AU - Paul, Mary
AU - Eser-Jose, Ruth
AU - McMullen-Jackson, Chivon
AU - Harris, Lynnette
AU - Purswani, Murli
AU - Baig, Mahoobullah Mirza
AU - Villegas, Alma
AU - Alvarado, Marvin
AU - Robinson, Lisa Gaye
AU - Cooley, Jawara Dia
AU - Blood, James
AU - Garvie, Patricia
AU - Borkowsky, William
AU - Deygoo, Nagamah Sandra
AU - Lewis, Jennifer
AU - Dieudonne, Arry
AU - Bettica, Linda
AU - Johnson, Juliette
AU - Surowiec, Karen
AU - Knapp, Katherine
AU - Russell-Bell, Jamie
AU - Wilkins, Megan
AU - Love, Stephanie
AU - Rosario, Nicolas
AU - Angeli-Nieves, Lourdes
AU - Olivera, Vivian
AU - Kohlhoff, Stephan
AU - Dennie, Ava
AU - Kaye, Jean
AU - Wallier, Jenny
AU - Craig, Karen
AU - Sirois, Patricia
AU - Hutto, Cecelia
AU - Hickman, Paige
AU - Huldtquist, Julie
AU - Marullo, Dan
AU - Spector, Stephen A.
AU - Rodriguez, Zoe M.
N1 - Publisher Copyright:
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.
PY - 2022/3/15
Y1 - 2022/3/15
N2 - Objective: The aim of this study was to compare long-term growth between HIV-exposed uninfected children (CHEU) born to women with perinatally acquired HIV (CHEU-PHIV) and CHEU born to women with nonperinatally acquired HIV (CHEU-NPHIV). Design: A longitudinal analysis of anthropometric measurements from a U.S.-based multisite prospective cohort study enrolling CHEU and their mothers since April 2007. Methods: CHEU were evaluated for growth annually from birth through age 5 and again at age 7 years. Z-scores were calculated using U.S. growth references for weight (WTZ), height (HTZ), and weight-for-length or BMI-for-age (WLZ/BMIZ). Mid-upper arm circumference (MUACZ) and triceps skinfold thickness (TSFZ) Z-scores were obtained from ages 1 and 2, respectively, through age 7 years. Piecewise mixed-effects models, overall and stratified by race and sex, were fit to assess differential growth patterns across age by maternal PHIV status. Results: One thousand four hundred fifty-four singleton infants (286 CHEU-PHIV and 1168 CHEU-NPHIV) were included. CHEU-PHIV had slower growth rates than CHEU-NPHIV for WTZ and WLZ/BMIZ at earlier ages and continued to have lower mean WTZ [-0.27, 95% confidence interval (95% CI): -0.50, -0.04] and WLZ/BMIZ (-0.39, 95% CI: -0.67, -0.11) through age 7. Among non-Black boys, CHEU-PHIV had slightly lower WTZ and WLZ/BMIZ at birth than CHEU-NPHIV and these growth deficits persisted through age 7 years. Conclusion: Compared with CHEU-NPHIV, CHEU-PHIV had diminished growth in early childhood with differences most pronounced among non-Black male children. Further longitudinal follow-up of CHEU-PHIV into young adulthood is needed to understand whether these early effects of maternal PHIV status on growth persist and have other health consequences.
AB - Objective: The aim of this study was to compare long-term growth between HIV-exposed uninfected children (CHEU) born to women with perinatally acquired HIV (CHEU-PHIV) and CHEU born to women with nonperinatally acquired HIV (CHEU-NPHIV). Design: A longitudinal analysis of anthropometric measurements from a U.S.-based multisite prospective cohort study enrolling CHEU and their mothers since April 2007. Methods: CHEU were evaluated for growth annually from birth through age 5 and again at age 7 years. Z-scores were calculated using U.S. growth references for weight (WTZ), height (HTZ), and weight-for-length or BMI-for-age (WLZ/BMIZ). Mid-upper arm circumference (MUACZ) and triceps skinfold thickness (TSFZ) Z-scores were obtained from ages 1 and 2, respectively, through age 7 years. Piecewise mixed-effects models, overall and stratified by race and sex, were fit to assess differential growth patterns across age by maternal PHIV status. Results: One thousand four hundred fifty-four singleton infants (286 CHEU-PHIV and 1168 CHEU-NPHIV) were included. CHEU-PHIV had slower growth rates than CHEU-NPHIV for WTZ and WLZ/BMIZ at earlier ages and continued to have lower mean WTZ [-0.27, 95% confidence interval (95% CI): -0.50, -0.04] and WLZ/BMIZ (-0.39, 95% CI: -0.67, -0.11) through age 7. Among non-Black boys, CHEU-PHIV had slightly lower WTZ and WLZ/BMIZ at birth than CHEU-NPHIV and these growth deficits persisted through age 7 years. Conclusion: Compared with CHEU-NPHIV, CHEU-PHIV had diminished growth in early childhood with differences most pronounced among non-Black male children. Further longitudinal follow-up of CHEU-PHIV into young adulthood is needed to understand whether these early effects of maternal PHIV status on growth persist and have other health consequences.
KW - Child development
KW - HIV-exposed uninfected infants
KW - Maternal
KW - Perinatal HIV infection
KW - Postnatal growth
UR - http://www.scopus.com/inward/record.url?scp=85125212583&partnerID=8YFLogxK
U2 - 10.1097/QAD.0000000000003136
DO - 10.1097/QAD.0000000000003136
M3 - Article
C2 - 34860195
AN - SCOPUS:85125212583
SN - 0269-9370
VL - 36
SP - 593
EP - 603
JO - AIDS
JF - AIDS
IS - 4
ER -